- Scorpius Holdings Inc., a contract development and manufacturing organisation (CDMO), is opening a new storage and testing facility in San Antonio, Texas.
- The expansion increases Scorpius’ warehouse facilities sevenfold and will feature specialized storage areas, quality control testing spaces, and a robust stability program.
Scorpius an integrated contract development and manufacturing organization (CDMO), is set to expand its operational footprint with the opening of a new storage and testing facility in San Antonio, Texas. The expansion, announced on May 20, 2024, is a strategic move to accommodate the company’s growing client base and meet the increasing demand for its biomanufacturing services.
The new facility increases Scorpius’ warehouse facilities more than sevenfold, from approximately 3,000 square feet to around 22,000 square feet. It is designed to meet or exceed industry standards with appropriate storage, continuity, and security controls for biopharmaceutical materials. The facility will feature specialized storage areas with temperatures maintained between -20°C and -80°C for raw materials, alongside spaces designated for contained sampling and quality control testing.
In addition to accommodating bulk drug substance storage, the facility will ensure clients’ products are stored under optimal conditions throughout the development and production cycles. A notable feature of the facility is a robust stability program, which will bolster Scorpius’ service offerings by providing in-house stability storage capabilities to foster a smooth transition into onsite testing.
Jeff Wolf, CEO of Scorpius Holdings, commented on the expansion, saying, “These new capabilities enable us to offer our clients continuity through their supply chain and meet their needs from process development through drug substance release. This strategic expansion reflects our commitment to excellence and our dedication to supporting our clients’ overall needs.”
Stay ahead of trends and best practices
